News | December 08, 2023
Operations disrupted at NATCO Pharma's Manali, Chennai factory
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
These regulatory approvals signify a significant milestone for Venus Remedies Limited
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The product has been in-licensed from Strides and will be commercialized by Amneal
The product is expected to be launched in FY25
Subscribe To Our Newsletter & Stay Updated
